SOST and metabolic dysfunction-associated steatotic liver disease: For NAFLD subjects, sclerostin showed a positive correlation with age and a negative correlation with height, body weight, WC, DBP, urea, ALT, AST, fasting insulin levels, HOMA-IR, TC, TG, γ-GGT, and ALP levels by Pearson analysis (Table 2).